Literature DB >> 25841937

Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'.

John Reynolds1, Gloria A Preston2, Barrak M Pressler3, Peter Hewins2, Michael Brown2, Aleeza Roth2, Elizabeth Alderman2, Donna Bunch2, J Charles Jennette2, H Terence Cook4, Ronald J Falk2, Charles D Pusey4.   

Abstract

'Autoantigen complementarity' is a theory proposing that the initiator of an autoimmune response is not necessarily the autoantigen or its molecular mimic, but may instead be a peptide that is 'antisense/complementary' to the autoantigen. We investigated whether such complementary proteins play a role in the immunopathogenesis of autoimmune glomerulonephritis. Experimental autoimmune glomerulonephritis, a model of anti-glomerular basement membrane (GBM) disease, can be induced in Wistar Kyoto (WKY) rats by immunization with the α3 chain of type IV collagen. In this study, WKY rats were immunized with a complementary α3 peptide (c-α3-Gly) comprised of amino acids that 'complement' the well characterized epitope on α3(IV)NC1, pCol(24-38). Within 8 weeks post-immunization, these animals developed cresentic glomerulonephritis, similar to pCol(24-38)-immunized rats, while animals immunized with scrambled peptide were normal. Anti-idiotypic antibodies to epitopes from c-α3-Gly-immunized animals were shown to be specific for α3 protein, binding in a region containing sense pCol(24-38) sequence. Interestingly, anti-complementary α3 antibodies were identified in sera from patients with anti-GBM disease, suggesting a role for 'autoantigen complementarity' in immunopathogenesis of the human disease. This work supports the idea that autoimmune glomerulonephritis can be initiated through an immune response against a peptide that is anti-sense or complementary to the autoantigen. The implications of this discovery may be far reaching, and other autoimmune diseases could be due to responses to these once unsuspected 'complementary' antigens.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-GBM disease; Autoantigen complementarity; Glomerular basement membrane

Mesh:

Substances:

Year:  2015        PMID: 25841937      PMCID: PMC4459745          DOI: 10.1016/j.jaut.2015.01.003

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  55 in total

1.  Segregation of experimental autoimmune glomerulonephritis as a complex genetic trait and exclusion of Col4a3 as a candidate gene.

Authors:  John Reynolds; Paul R Cook; James J Ryan; Penny J Norsworthy; Anne M Glazier; Mark A Duda; David J Evans; Timothy J Aitman; Ccharles D Pusey
Journal:  Exp Nephrol       Date:  2002

2.  Adjuvant regulation of cytokine profile and antibody isotype of immune responses to Mycoplasma agalactiae in mice.

Authors:  Nicolaos Avramidis; Panayiotis Victoratos; Minas Yiangou; L Hadjipetrou-Kourounakis
Journal:  Vet Microbiol       Date:  2002-09-24       Impact factor: 3.293

3.  Epitope mapping by mass spectrometry: determination of an epitope on HIV-1 IIIB p26 recognized by a monoclonal antibody.

Authors:  C E Parker; D I Papac; S K Trojak; K B Tomer
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

Review 4.  Crescentic glomerulonephritis: new aspects of pathogenesis.

Authors:  Ruth M Tarzi; H Terence Cook; Charles D Pusey
Journal:  Semin Nephrol       Date:  2011-07       Impact factor: 5.299

5.  Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease.

Authors:  Stephen W Olson; Charles B Arbogast; Thomas P Baker; David Owshalimpur; David K Oliver; Kevin C Abbott; Christina M Yuan
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

6.  Associations of HLA-DR and HLA-DQ types with anti-GBM nephritis by sequence-specific oligonucleotide probe hybridization.

Authors:  B Huey; K McCormick; J Capper; C Ratliff; B W Colombe; M R Garovoy; C B Wilson
Journal:  Kidney Int       Date:  1993-08       Impact factor: 10.612

Review 7.  Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.

Authors:  A Billiau; P Matthys
Journal:  J Leukoc Biol       Date:  2001-12       Impact factor: 4.962

8.  The Wistar Kyoto (RT1(l)) rat is resistant to myelin basic protein-induced experimental autoimmune encephalomyelitis: comparison with the susceptible Lewis (RT1(l)) strain with regard to the MBP-directed CD4+ T cell repertoire and its regulation.

Authors:  David B Stevens; Daniel P Gold; Eli E Sercarz; Kamal D Moudgil
Journal:  J Neuroimmunol       Date:  2002-05       Impact factor: 3.478

9.  Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen.

Authors:  N Turner; P J Mason; R Brown; M Fox; S Povey; A Rees; C D Pusey
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

10.  Genetic susceptibility to experimental autoimmune glomerulonephritis in the Wistar Kyoto rat.

Authors:  John Reynolds; Paul R Cook; Jacques Behmoaras; Jennifer Smith; Gurjeet Bhangal; Susan Tadros; Jonathan Tee; Alan D Salama; David J Evans; Timothy J Aitman; H Terence Cook; Charles D Pusey
Journal:  Am J Pathol       Date:  2012-03-22       Impact factor: 4.307

View more
  5 in total

Review 1.  Overview of the Pathogenesis of ANCA-Associated Vasculitis.

Authors:  Hong Xiao; Peiqi Hu; Ronald J Falk; J Charles Jennette
Journal:  Kidney Dis (Basel)       Date:  2015-12-03

2.  Clustering of Anti-GBM Disease: Clues to an Environmental Trigger?

Authors:  Stephen P McAdoo; Charles D Pusey
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

3.  Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis.

Authors:  Mandy Sowa; Barbara Trezzi; Rico Hiemann; Peter Schierack; Kai Grossmann; Juliane Scholz; Valentina Somma; Renato Alberto Sinico; Dirk Roggenbuck; Antonella Radice
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

4.  Atypical anti-glomerular basement membrane disease: lessons learned.

Authors:  Richard J Glassock
Journal:  Clin Kidney J       Date:  2016-07-28

Review 5.  Anti-Glomerular Basement Membrane Disease.

Authors:  Stephen P McAdoo; Charles D Pusey
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-17       Impact factor: 8.237

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.